Symprove is a water-based probiotic that delivers billions of live and active bacteria to the gut.  The healthy bacteria arrive safely in the gut, surviving the harsh environment of the stomach, before multiplying rapidly, thriving and colonising in the gut. This process has been scientifically proven by independent clinical trials in collaboration with research partners including University College London and King’s College London. With existing studies in IBS and IBD completed, Symprove and its key research partners have several more studies underway, including new research on IBS, which will be published in 2024.

Having gained an impressive and loyal customer base since its launch to the market, alongside backing from clinical experts, Symprove allows people to take control of their gut and currently boasts an impressive 4.5* TrustPilot score.